排序方式:
    總頁 1 
      Go

    1.S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung

    Hao, Mengyao, Fu, Ro     More...

    Acta Pharmaceutica Sinica B[2211-3835], Published 2023, Volume 13, Issue 3, Pages 1110-1127

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2022影響因子:  14.5 

    2.SMYD3-PARP16 axis accelerates unfolded protein response and mediates neointima formation

    Long, F, Yang, D, Wa     More...

    ACTA PHARMACEUTICA SINICA B[2211-3835], Published 2021, Volume 11, Issue 5, Pages 1261-1273

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 12  2022影響因子:  14.5  发表年影響因子:  14.907 

    顯示      條  合計   2   條
      總頁 1 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫